In multivariate models, BLR was a significant predictor for both RFS and distant RFS after adjustment for tumor stage (model 1), hormone receptor status (model 2), serum inflammatory marker (model 3), and PET/CT parameters of primary tumor (model 4). The gene discussed is NR4A1; the disease is neoplasm.